• FirefoxUpgrade to the new Firefox »
  •  Dow Down 2.07% Nasdaq Down 2.13%

    More On LLTP

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    Lightlake Therapeutics Inc (LLTP)

    -Other OTC
    0.05 Down 0.01(15.83%) Dec 30
    Add to Portfolio
    Prev Close:0.06
    Open:0.05
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:6.35
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.02 - 0.07
    Volume:0
    Avg Vol (3m):101,773
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LLTP

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Lightlake Therapeutics Inc., an early stage biopharmaceutical company, develops treatments for common addictions and related disorders. It focuses on developing a treatment to reverse opioid overdoses; a treatment for overweight and obese patients... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback